[Therapy of parkinsonism using L-dopa. I].
D000547:Amantadine / Q000627:therapeutic use; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy*
D006834:Hydrazines; D008996:Monoamine Oxidase Inhibitors; D004295:Dihydroxyphenylalanine; D000547:Amantadine
Die Behandlung des Parkinson-Syndroms mit L-Dopa.